| Neuroepithelial Neoplasm altered in cohorts of …ALTERED_INderived200 of 430show all (up to 200) |
|---|
| ← altered in cohorts of | ATRNL1 456 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYOF 456 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC23IP 456 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BAG3 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CACUL1 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF3A 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INPP5F 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MCMBP 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRLHR 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SORBS1 455 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTA2 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CTBP2 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP26C1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND10 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GFRA1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRK5 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HSPA12A 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPK 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NANOS1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDZD8 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLPP4 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PNLIPRP1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PNLIPRP3 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRDX3 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAB11FIP2 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RGS10 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SFXN4 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC18A2 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBC1D12 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TIAL1 454 / 601 cases (76 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABRAXAS2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD22 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATE1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C10orf82 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC172 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CPXM2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP26A1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP2C18 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMBT1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DOCK1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EMX2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ENO4 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ENTPD1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EXOC6 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM204A 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM53B 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAS 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FGFR2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HELLS 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFIT5 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNK18 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LHPP 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPF 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPJ 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPM 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPN 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MKI67 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NOC3L 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OAT 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDE6C 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDLIM1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLCE1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PNLIP 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNLS 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHTN1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STAMBPL1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TACC2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TLL2 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VAX1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WDR11 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZRANB1 453 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACADSB 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATAD1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BLNK 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BTBD16 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BUB3 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CEP55 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP2C8 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP2C9 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DHX32 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EDRF1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM24B 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FRA10AC1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR26 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HMX3 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IDE 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFIT1B 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IFIT3 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLLN 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LGI1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NKX1-2 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NSMCE4A 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PKD2L1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBP4 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC35G1 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNKS2 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF518A 452 / 601 cases (75 %) · ssm · TCGA-GBM | — | — | Glioblastoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TERT 604 / 882 cases (68 %) · ssm · glioma_mskcc_2019 · largest of 4 cohorts | — | — | Diffuse Glioma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NLRP5 284 / 516 cases (55 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLRP2 283 / 516 cases (55 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLRP11 282 / 516 cases (55 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLRP8 282 / 516 cases (55 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PEG3 282 / 516 cases (55 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP1R12C 282 / 516 cases (55 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPS8L1 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FIZ1 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GP6 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LILRA1 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLRP13 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLRP4 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLRP7 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NLRP9 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTPRH 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF460 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF470 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF551 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF581 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF667 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF671 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSCAN1 281 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | A1BG 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BRSK1 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC106 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COX6B2 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPN1 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM71E2 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL11 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ISOC2 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KMT5C 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LENG9 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NAT14 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RDH13 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RFPL4A 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RFPL4AL1 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL28 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SBK2 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SBK3 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHISA7 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SSC5D 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYT5 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM150B 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM190 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM238 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNNT1 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | U2AF2 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBE2S 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP29 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF134 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF154 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF264 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF274 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF416 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF471 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF544 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF549 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF579 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF580 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF583 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF606 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF628 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF71 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF772 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF784 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF835 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF865 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSCAN18 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSCAN5A 280 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAAF3 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DUXA 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERVK3-1 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GALP 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HSPBP1 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KIR2DL1 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCR1 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP6R1 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMIM17 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM86B 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIM28 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFP28 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZIK1 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZIM2 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF304 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF418 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF444 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF497 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF524 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF547 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF749 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF787 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF8 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF805 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSCAN22 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSCAN4 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSCAN5B 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZSCAN5C 279 / 516 cases (54 %) · ssm · TCGA-LGG | — | — | Low Grade Glioma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TAS2R46 46 / 105 cases (44 %) · ssm · gbm_mayo_pdx_sarkaria_2019 | — | — | Diffuse Glioma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PABPC3 44 / 105 cases (42 %) · ssm · gbm_mayo_pdx_sarkaria_2019 | — | — | Diffuse Glioma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC2 43 / 105 cases (41 %) · ssm · gbm_mayo_pdx_sarkaria_2019 | — | — | Diffuse Glioma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRBV7-7 43 / 105 cases (41 %) · ssm · gbm_mayo_pdx_sarkaria_2019 | — | — | Diffuse Glioma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 405 / 1,004 cases (40 %) · ssm · glioma_mskcc_2019 · largest of 17 cohorts | — | — | Diffuse Glioma | 17 | Observed | cbioportal | graph → |